Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.
Ksenia V KastanenkaThierry BussiereNaomi ShakerdgeFang QianPaul H WeinrebKen RhodesBrian J BacskaiPublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2016)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is currently without a cure. Aducanumab is an anti-amyloid-β antibody being developed for the treatment of AD. Interim analyses of a phase 1b clinical trial have suggested potential beneficial effects on amyloid pathology and cognitive status in patients treated with aducanumab (Sevigny et al., 2016). Here, we show that a murine analog of aducanumab clears amyloid plaques in an acute setting and restores calcium homeostasis disrupted in a mouse model of AD upon chronic treatment. Therefore, we demonstrate that aducanumab reverses a functional outcome measure reflective of neural network activity.